LXCHEM.BO(LXCHEM.BO)
LXCHEM.BO
No analyst ratings available
No analyst price targets available for LXCHEM.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $54.90B | $61.87B |
| Low | $49.05B | $50.68B |
| High | $60.76B | $73.06B |
| EBITDA Avg | $5.17B | $5.83B |
| Low | $4.62B | $4.77B |
| High | $5.72B | $6.88B |
| EBIT Avg | $3.55B | $4.00B |
| Low | $3.17B | $3.28B |
| High | $3.93B | $4.72B |
| Net Income Avg | $2.27B | $2.78B |
| Low | $1.95B | $1.87B |
| High | $2.58B | $3.70B |
| EPS Avg | $8.17 | $10.03 |
| Low | $7.03 | $6.74 |
| High | $9.30 | $13.33 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 |
| Metric | Q2 2026 |
|---|---|
| Revenue Avg | $7.29B |
| Low | $7.29B |
| High | $7.29B |
| EBITDA Avg | $687M |
| Low | $687M |
| High | $687M |
| EBIT Avg | $472M |
| Low | $472M |
| High | $472M |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |